HWM
PLRX icon

HighMark Wealth Management’s Pliant Therapeutics PLRX Stock Holding History

HighMark Wealth Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$209K Sell
166,224
-4,700
-3% -$5.93K 0.09% 75
2025
Q4 		$209K Sell
170,924
-48,076
-22% -$72.2K 0.09% 73
2025
Q3 		$324K Buy
219,000
+78,000
+55% +$119K 0.14% 60
2025
Q2 		$164K Sell
141,000
-16,500
-10% -$23.3K 0.08% 84
2025
Q1 		$213K Buy
157,500
+82,500
+110% +$501K 0.13% 52
2024
Q4 		$988K Buy
75,000
+7,500
+11% +$102K 0.57% 22
2024
Q3 		$757K Hold
67,500
– – 0.41% 32
2024
Q2 		$726K Buy
67,500
+25,000
+59% +$322K 0.44% 30
2024
Q1 		$633K Buy
42,500
+19,000
+81% +$313K 0.39% 33
2023
Q4 		$426K Buy
+23,500
New +$357K 0.31% 35

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return